Zhou Jingjing, Zhou Jia, Feng Zizhao, Feng Lei, Xiao Le, Chen Xu, Yang Jian, Feng Yuan, Wang Gang
Beijing Key Laboratory of Mental Disorders, National Clinical Research Center for Mental Disorders & National Center for Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, China; Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, China.
Beijing Key Laboratory of Mental Disorders, National Clinical Research Center for Mental Disorders & National Center for Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, China; Advanced Innovation Center for Human Brain Protection, Capital Medical University, Beijing, China.
Gen Hosp Psychiatry. 2024 Mar-Apr;87:68-76. doi: 10.1016/j.genhosppsych.2024.01.012. Epub 2024 Feb 1.
To identify the core residual symptom of MDD and assess its relationship with patients' long-term outcomes.
All patients were administered antidepressants during the acute phase and treated continuously. The 521 patients remitted at month 6 of a multicenter prospective project were included. Remission was defined as a Quick Inventory of Depressive Symptoms-Self-Report total score of ≤5. Functional impairments were measured with the Sheehan Disability Scale, quality of life with the Quality of Life Enjoyment and Satisfaction Questionnaire - short form, and family burden with the Family Burden Scale of Disease. Visits were scheduled at baseline, weeks 2, 8, 12, and month 6.
Difficulty with concentration/decision making was the core residual symptom of MDD, determined with the centrality measure of network analysis. It was positively associated with functional impairments and family burden (r = 0.35, P < 0.01 and r = 0.31, P < 0.01, respectively) and negatively associated with life satisfaction (r = -0.29, P < 0.01). The exhibition of this residual symptom was associated with a family history of psychiatric disorders (OR = 2.610 [1.242-5.485]).
The core residual symptom of MDD, difficulty with concentration/decision making, is associated with poorer social functioning, heavier family burden, and lower life satisfaction. Early detection and intervention of this symptom may be beneficial.
(Chinese Clinical Trials.gov identifier) ChiCTR-OOC-17012566 and ChiCTR-INR-17012574.
确定重度抑郁症(MDD)的核心残留症状,并评估其与患者长期预后的关系。
所有患者在急性期均接受抗抑郁药治疗并持续治疗。纳入了一个多中心前瞻性项目中在第6个月缓解的521例患者。缓解定义为抑郁症状快速自评量表总分≤5分。使用希恩残疾量表测量功能损害,使用生活享受与满意度问卷简表测量生活质量,使用疾病家庭负担量表测量家庭负担。在基线、第2周、第8周、第12周和第6个月安排随访。
注意力不集中/决策困难是MDD的核心残留症状,通过网络分析的中心性测量确定。它与功能损害和家庭负担呈正相关(r分别为0.35,P<0.01和r为0.31,P<0.01),与生活满意度呈负相关(r=-0.29,P<0.01)。这种残留症状的出现与精神疾病家族史相关(OR=2.610[1.242-5.485])。
MDD的核心残留症状,即注意力不集中/决策困难,与较差的社会功能、较重的家庭负担和较低的生活满意度相关。早期发现和干预这种症状可能有益。
(中国临床试验注册中心标识符)ChiCTR-OOC-17012566和ChiCTR-INR-17012574。